Miguel Escobar/WFH
Aug 2, 2025, 16:50
Chromogenic Assays Underused in Females with Hemophilia A
The World Federation of Hemophilia (WFH) shared a post on X:
”A global survey of hemophilia providers shows that chromogenic assays versus one stage assays are ordered far less often in females than males—pointing to gaps in access, awareness, and clinical approach.
Read the full article.”
Article: Chromogenic vs one-stage assay to diagnose women and girls with hemophilia A—mapping global approaches and assessing challenges: communication from the SSCs of the ISTH
Authors: Lakshmi Srivaths, Joanna Larson, Karin Fijnvandraat, Jesus Ardila, Miguel Escobar
Find similar posts on Hemostasis Today.
-
Feb 16, 2026, 15:44Lakmali Silva: Silva Lab Showcases Research at the Gordon Research Conference on Plasminogen and Extracellular Proteolysis
-
Feb 16, 2026, 15:36Heghine Khachatryan: Strengthening Maternal Resilience Against Postpartum Hemorrhage
-
Feb 16, 2026, 15:34Sevak Mirabyan: Advancing Cancer Care Through Knowledge, Collaboration, and Early Diagnosis in Armenia
-
Feb 16, 2026, 15:29Chokri Ben Lamine: Key Clinical Insights of Drug Induced Thrombocytopenia
-
Feb 16, 2026, 15:28Ney Carter Borges: Coronary Intravascular Lithotripsy – Clinical Performance and Safety
-
Feb 16, 2026, 15:24Flora Peyvandi: Highlighting Overdose, Homicide, and Suicide as Causes of Maternal Death in the US
-
Feb 16, 2026, 14:53Wafaa Abougabal: Differential Diagnosis of Acute Neurologic Deficits and Stroke in PICU
-
Feb 16, 2026, 14:49Nayab Ahmed: Synthesis of ATP and Its Significance in Storage of Blood
-
Feb 16, 2026, 14:44Lukasz Kuzma: NOAC Monotherapy vs NOAC Plus Clopidogrel in AF Beyond One Year After DES